FACTOR II (PROTHROMBIN) Mutation Study PFH373
Includes:
Sample: Peripheral Blood in EDTA (3 ml)
Methodology: PCR
Reporting: 6 Days (11:00)
Factor-IX PFH374
Includes:
Sample: Na Citrate - Plasma (3 ml)
Methodology: Clotting
Reporting: 2 & 4 & 1 (11:00)
Factor-V PFH375
Includes:
Sample: Citrated Plasma (1ml)
Methodology: Clotting
Reporting: 2 & 4 & 6 (11:00)
Factor-V Leiden Mutation - Qualitative PFH376
Includes:
Sample: WB-EDTA Plasma (3ml)
Methodology: RTPCR
Reporting: 3 & 6 (11:00)
Factor-VIII PFH377
Includes:
Sample: Na Citrate - Plasma (3 ml)
Methodology: Clotting
Reporting: 2 & 4 & 1 (11:00)
Ferritin PFH378
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: Next day (11:00)
Ferritin - Titre PFH379
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Fibrinogen PFH380
Includes:
Sample: Na Citrate - Plasma (3 ml)
Methodology: Clotting
Reporting: 11:00/19:00
Fibrinogen Degradation Product (FDP) PFH381
Includes:
Sample: Na Citrate - Plasma (3 ml)
Methodology: Slide Agglutination
Reporting: 11:00/19:00
Fish PFH382
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
FISH for CLL Panel PFH383
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 9 days (11:00)
FISH, BCR/ABL, t (9;22) PFH384
Includes:
Sample: Peripheral Blood/Bone Marrow - Na Heparin (3ml)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, CBFB, Inv (16) PFH385
Includes:
Sample: Peripheral Blood/Bone Marrow - Na Heparin (3ml)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, Di-George Syndrome (Chromosome 22 q Deletion) PFH386
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 9 days (11:00)
FISH, ETO/AML1, t (8;21) PFH387
Includes:
Sample: Peripheral Blood/Bone Marrow - Na Heparin (3ml)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, Her-2 Neu Oncogene Amplification, Breast Cancer PFH388
Includes:
Sample: Paraffin Blocks
Methodology: FISH
Reporting: 6 days (11:00)
FISH, IGH/C-MYC (8;14) Burkitt Lymphoma PFH389
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, Neonatal Screen (Trisomy 21, 18, 13, X,Y) PFH390
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, PML/RARA, t (15;17) PFH391
Includes:
Sample: Peripheral Blood/Bone Marrow - Na Heparin (3ml)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, Prenatal Aneuploidy Detection-Amino (2 Probes- Trisomy 21 & 13) PFH392
Includes:
Sample: Amniotic Fluid - Sterile Falcon Tubes (10-20ml)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, Prenatal Aneuploidy Detection-Amino (3 Probes- Trisomy 18, X, Y) PFH393
Includes:
Sample: Amniotic Fluid - Sterile Falcon Tubes (10-20ml)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, Prenatal Aneuploidy Detection-Amino (5 Probes- Trisomy 21, 18, 13, X, Y) PFH394
Includes:
Sample: Amniotic Fluid - Sterile Falcon Tubes (10-20ml)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, Prenatal Aneuploidy Detection-CVS (2 Probes- Trisomy 21 & 13) PFH395
Includes:
Sample: Chorionic Villi - Sterile Falcon Tubes in Normal Saline (>25 mg)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, Prenatal Aneuploidy Detection-CVS (3 Probes- Trisomy 18, X, Y) PFH396
Includes:
Sample: Chorionic Villi - Sterile Falcon Tubes in Normal Saline (>25 mg)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, Prenatal Aneuploidy Detection-CVS (5 Probes- Trisomy 21, 18, 13; X, Y) PFH397
Includes:
Sample: Chorionic Villi - Sterile Falcon Tubes in Normal Saline (>25 mg)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, Prenatal Aneuploidy Detection-CVS (5 Probes- Trisomy 21, 18, 13; X, Y) PFH398
Includes:
Sample: Fetal Cord Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 6 days (11:00)
FISH, TEL/AML1, t(12;21) PFH399
Includes:
Sample: Peripheral Blood/Bone Marrow - Na Heparin (3ml)
Methodology: FISH
Reporting: 6 days (11:00)
FISH,? MLL-AF4 (4;11) ALL PFH400
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 6 days (11:00)
FISH-11q23 PFH401
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 9 days (11:00)
FISH-17p PFH402
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 9 days (11:00)
FISH-del 13q PFH403
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 9 days (11:00)
FISH-EGFR Gene Amplification PFH404
Includes:
Sample: Slides/Blocks
Methodology: FISH
Reporting: 9 days (11:00)
FISH-MDS PANEL PFH405
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 9 days (11:00)
FISH-Multiple Myeloma PFH406
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 9 days (11:00)
FISH-Prader-villi PFH407
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 9 days (11:00)
FISH-t (11:14) PFH408
Includes:
Sample: Peripheral Blood - Na Heparin (3ml)
Methodology: FISH
Reporting: 9 days (11:00)
Flourscenced Taged Antibodies (FTA-Abs) PFH409
Includes:
Sample: Serum (1 ml)
Methodology: Immunofluorescence
Reporting: 11:00/18:00
FLT3 ? ITD (Fetal Liver Tyrosine Kinase) PFH410
Includes:
Sample: Peripheral Blood in EDTA (3 ml)
Methodology: PCR
Reporting: 6 Days (11:00)
Fluid Cell Count PFH411
Includes:
Sample: Fluid (5 ml)
Methodology: Chamber Count
Reporting: 11:00/19:00
Fluid Examination - Routine, PFH412
Includes:
Sample: CSF (1ml)
Methodology: Spect/Microscopy
Reporting: Next day (11:00)
Fluid Examination - Routine, PFH413
Includes:
Sample: Pleural Fluid (1ml)
Methodology: Spect/Microscopy
Reporting: Next day (11:00)
Fluid Examination - Routine, PFH414
Includes:
Sample: Ascitic Fluid (1ml)
Methodology: Spect/Microscopy
Reporting: Next day (11:00)
Fluid Examination - Routine, PFH415
Includes:
Sample: Synovial Fluid (1ml)
Methodology: Spect/Microscopy
Reporting: Next day (11:00)
Fluid Examination - Routine, PFH416
Includes:
Sample: Other Fluids (1ml)
Methodology: Spect/Microscopy
Reporting: Next day (11:00)
FMC-7 (Prognostic CLL / NHL Marker) PFH417
Includes:
Sample: 2 - 3 ml - whole blood in EDTA/Bone marrow in Sodium Heparin (transport in 4 deg C)
Methodology: Flow Cytometry
Reporting: 2 & 4 & 6 (19:00)
Folic Acid (Folate) PFH418
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Follicle Stimulating Hormone (FSH) PFH419
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Fragile X Syndrome (FMRI Gene) PFH420
Includes:
Sample: Peripheral Blood in EDTA (3 ml)
Methodology: PCR
Reporting: 7 Days (11:00)
Free Androgen Index PFH421
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: Next day (11:00)
Free Light Chains (Kappa & Lambda) PFH422
Includes:
Sample: Serum (1 ml)
Methodology: Immunoturbidometry
Reporting: Next day (11:00)
Fructosamine PFH423
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Fungal Stain PFH424
Includes:
Sample: Urine / Swab / Pus / Nail / Hair / Sputum / Body Fluids/ CSF / Skin scrappings
Methodology: Microscopy
Reporting: Next Day (11:00)